The mother and daughter received identical diagnoses just over a year apart of multiple myeloma, a blood cancer that occurs ...

Dr. Thejus Jayakrishnan sat down with CURE at the 2026 ASCO Gastrointestinal Cancers Symposium to discuss research he ...

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic regimens ...

Doctronic reports on top OTC and prescription flu medicines, emphasizing symptom relief and the importance of early antiviral ...

Until about five years ago, scientists believed the pregnancy hormone, human chorionic gonadotropin (hCG), was the culprit.

Dr. Shereene Idriss, board-certified dermatologist and the founder of Idriss Dermatology in New York City: Number one is ...

A small Canadian province feared it had a mystery neurological illness on its hands. The search for answers set off a battle ...

Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ...

Topline data were announced from two phase 3 studies evaluating setrusumab in patients with osteogenesis imperfecta.

Silence from Scripture on new technologies and the ethical questions they raise is no excuse for silence from the church.

As of Friday, January 09, Heron Therapeutics, Inc.’s HRTX share price has surged by 18.11%, which has investors questioning ...